Literature DB >> 19234216

Anti-inflammatory role of IL-17 in experimental autoimmune uveitis.

Yan Ke1, Ke Liu, Guo-Qiang Huang, Yan Cui, Henry J Kaplan, Hui Shao, Deming Sun.   

Abstract

Previous studies have shown that IL-17 is a strong proinflammatory cytokine and that IL-17-producing autoreactive T cells play a major role in the pathogenesis of autoimmune diseases. In a previous study, we showed that injection of experimental autoimmune uveitis-susceptible mice with anti-IL-17 Abs blocked subsequent disease development. To determine whether administration of IL-17 to experimental autoimmune uveitis-susceptible Lewis rats and B10RIII mice injected with disease-inducing peptides enhanced disease susceptibility, we injected the recipient animals with various doses of human rIL-17 (hIL-17). Unexpectedly, the treated animals showed significant amelioration of disease; in addition, both the intensity of the autoreactive response and cytokine production by the autoreactive T cells induced by immunization with uveitogenic peptides were significantly decreased. Our results show that IL-17 has anti-inflammatory activity and that this cytokine can suppress the development of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234216      PMCID: PMC3275433          DOI: 10.4049/jimmunol.0802487

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Cutting edge: anti-inflammatory properties of low levels of IFN-gamma.

Authors:  Liat Flaishon; Ian Topilski; David Shoseyov; Rami Hershkoviz; Elizabeth Fireman; Yoram Levo; Sylvia Marmor; Idit Shachar
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

2.  Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis.

Authors:  H Shao; M D Woon; S Nakamura; J H Sohn; P A Morton; N S Bora; H J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-08       Impact factor: 4.799

3.  A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis.

Authors:  U Christen; T Wolfe; U Möhrle; A C Hughes; E Rodrigo; E A Green; R A Flavell; M G von Herrath
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

4.  IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis.

Authors:  E Lubberts; L A Joosten; B Oppers; L van den Bersselaar; C J Coenen-de Roo; J K Kolls; P Schwarzenberger; F A van de Loo; W B van den Berg
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

5.  Effector function of resting T cells: activation of synovial fibroblasts.

Authors:  Y Yamamura; R Gupta; Y Morita; X He; R Pai; J Endres; A Freiberg; K Chung; D A Fox
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

6.  IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases.

Authors:  M Laan; J Lötvall; K F Chung; A Lindén
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

7.  Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis.

Authors:  R Di Marco; M Khademi; E Wallstrom; E Iacobaeus; A Salvaggio; S Caracappa; R Papoian; F Nicoletti; T Olsson
Journal:  J Neuroimmunol       Date:  2001-06-01       Impact factor: 3.478

8.  Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis.

Authors:  P Schwarzenberger; W Huang; P Ye; P Oliver; M Manuel; Z Zhang; G Bagby; S Nelson; J K Kolls
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

9.  IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells.

Authors:  J Witowski; K Pawlaczyk; A Breborowicz; A Scheuren; M Kuzlan-Pawlaczyk; J Wisniewska; A Polubinska; H Friess; G M Gahl; U Frei; A Jörres
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

10.  Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.

Authors:  Guomin Jiang; Yan Ke; Deming Sun; Gencheng Han; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

View more
  52 in total

1.  Characterization of autoreactive and bystander IL-17+ T cells induced in immunized C57BL/6 mice.

Authors:  Hong Nian; Dongchun Liang; Aijun Zuo; Ruihua Wei; Hui Shao; Willi K Born; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

2.  PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells.

Authors:  Yan Ke; Deming Sun; Guomin Jiang; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2010-08-25       Impact factor: 4.962

3.  Impact of interleukin-17 on macrophage phagocytosis of apoptotic neutrophils and particles.

Authors:  Elin Silverpil; Pernilla Glader; Marit Hansson; Anders Lindén
Journal:  Inflammation       Date:  2011-02       Impact factor: 4.092

Review 4.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

5.  Commercial rodent diets differentially regulate autoimmune glomerulonephritis, epigenetics and microbiota in MRL/lpr mice.

Authors:  Michael R Edwards; Rujuan Dai; Bettina Heid; Thomas E Cecere; Deena Khan; Qinghui Mu; Catharine Cowan; Xin M Luo; S Ansar Ahmed
Journal:  Int Immunol       Date:  2017-06-01       Impact factor: 4.823

6.  Gaining entry to an uninflamed brain.

Authors:  Robert C Axtell; Lawrence Steinman
Journal:  Nat Immunol       Date:  2009-05       Impact factor: 25.606

7.  Retinal Astrocytes respond to IL-17 differently than Retinal Pigment Epithelial cells.

Authors:  Yan Ke; Guomin Jiang; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2009-08-18       Impact factor: 4.962

Review 8.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

Review 9.  Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis.

Authors:  Kathryn L Pepple; Phoebe Lin
Journal:  Ophthalmology       Date:  2018-07-04       Impact factor: 12.079

10.  Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.

Authors:  Wei Chi; Peizeng Yang; Xuefei Zhu; Yuqin Wang; Lina Chen; Xiangkun Huang; Xiaoli Liu
Journal:  Mol Vis       Date:  2010-05-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.